Insider Transactions in Q4 2023 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2023
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
9,316
-35.39%
|
$177,004
$19.13 P/Share
|
|
Dec 19
2023
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,316
+26.14%
|
$121,108
$13.88 P/Share
|
|
Dec 07
2023
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
28,600
-11.4%
|
$486,200
$17.69 P/Share
|
|
Dec 07
2023
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
28,600
+28.01%
|
$28,600
$1.86 P/Share
|
|
Nov 03
2023
|
Richard S Levy |
BUY
Exercise of conversion of derivative security
|
Direct |
2,777
+26.31%
|
-
|
|
Oct 04
2023
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-0.3%
|
$832
$16.01 P/Share
|
|
Oct 04
2023
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+1.02%
|
-
|